Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Gynecomastia Procedure Market

ID: MRFR/HC/35375-HCR
100 Pages
Satyendra Maurya
Last Updated: April 15, 2026

Gynecomastia Procedure Market Research Report By Procedure Type (Liposuction, Mastectomy, Thyroid Hormone Therapy, Medications, Ultrasound), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers), By Gender (Male, Female), By Age Group (Adolescents, Adults, Elderly) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Gynecomastia Procedure Market Infographic
Purchase Options
  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Healthcare, BY Procedure Type (USD Billion) | |
      1. 4.1.1 Liposuction | |
      2. 4.1.2 Mastectomy | |
      3. 4.1.3 Thyroid Hormone Therapy | |
      4. 4.1.4 Medications | |
      5. 4.1.5 Ultrasound |
    2. 4.2 Healthcare, BY End User (USD Billion) | |
      1. 4.2.1 Hospitals | |
      2. 4.2.2 Specialty Clinics | |
      3. 4.2.3 Ambulatory Surgical Centers |
    3. 4.3 Healthcare, BY Gender (USD Billion) | |
      1. 4.3.1 Male | |
      2. 4.3.2 Female |
    4. 4.4 Healthcare, BY Age Group (USD Billion) | |
      1. 4.4.1 Adolescents | |
      2. 4.4.2 Adults | |
      3. 4.4.3 Elderly |
    5. 4.5 Healthcare, BY Region (USD Billion) | |
      1. 4.5.1 North America | | |
        1. 4.5.1.1 US | | |
        2. 4.5.1.2 Canada | |
      2. 4.5.2 Europe | | |
        1. 4.5.2.1 Germany | | |
        2. 4.5.2.2 UK | | |
        3. 4.5.2.3 France | | |
        4. 4.5.2.4 Russia | | |
        5. 4.5.2.5 Italy | | |
        6. 4.5.2.6 Spain | | |
        7. 4.5.2.7 Rest of Europe | |
      3. 4.5.3 APAC | | |
        1. 4.5.3.1 China | | |
        2. 4.5.3.2 India | | |
        3. 4.5.3.3 Japan | | |
        4. 4.5.3.4 South Korea | | |
        5. 4.5.3.5 Malaysia | | |
        6. 4.5.3.6 Thailand | | |
        7. 4.5.3.7 Indonesia | | |
        8. 4.5.3.8 Rest of APAC | |
      4. 4.5.4 South America | | |
        1. 4.5.4.1 Brazil | | |
        2. 4.5.4.2 Mexico | | |
        3. 4.5.4.3 Argentina | | |
        4. 4.5.4.4 Rest of South America | |
      5. 4.5.5 MEA | | |
        1. 4.5.5.1 GCC Countries | | |
        2. 4.5.5.2 South Africa | | |
        3. 4.5.5.3 Rest of MEA 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Healthcare | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 Allergan (US) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 Galderma (CH) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 Ipsen (FR) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 Medytox (KR) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 Revance Therapeutics (US) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 Sientra (US) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 Hugel (KR) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 Medytox (KR) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 NORTH AMERICA MARKET ANALYSIS |
    6. 6.3 US MARKET ANALYSIS BY PROCEDURE TYPE |
    7. 6.4 US MARKET ANALYSIS BY END USER |
    8. 6.5 US MARKET ANALYSIS BY GENDER |
    9. 6.6 US MARKET ANALYSIS BY AGE GROUP |
    10. 6.7 CANADA MARKET ANALYSIS BY PROCEDURE TYPE |
    11. 6.8 CANADA MARKET ANALYSIS BY END USER |
    12. 6.9 CANADA MARKET ANALYSIS BY GENDER |
    13. 6.10 CANADA MARKET ANALYSIS BY AGE GROUP |
    14. 6.11 EUROPE MARKET ANALYSIS |
    15. 6.12 GERMANY MARKET ANALYSIS BY PROCEDURE TYPE |
    16. 6.13 GERMANY MARKET ANALYSIS BY END USER |
    17. 6.14 GERMANY MARKET ANALYSIS BY GENDER |
    18. 6.15 GERMANY MARKET ANALYSIS BY AGE GROUP |
    19. 6.16 UK MARKET ANALYSIS BY PROCEDURE TYPE |
    20. 6.17 UK MARKET ANALYSIS BY END USER |
    21. 6.18 UK MARKET ANALYSIS BY GENDER |
    22. 6.19 UK MARKET ANALYSIS BY AGE GROUP |
    23. 6.20 FRANCE MARKET ANALYSIS BY PROCEDURE TYPE |
    24. 6.21 FRANCE MARKET ANALYSIS BY END USER |
    25. 6.22 FRANCE MARKET ANALYSIS BY GENDER |
    26. 6.23 FRANCE MARKET ANALYSIS BY AGE GROUP |
    27. 6.24 RUSSIA MARKET ANALYSIS BY PROCEDURE TYPE |
    28. 6.25 RUSSIA MARKET ANALYSIS BY END USER |
    29. 6.26 RUSSIA MARKET ANALYSIS BY GENDER |
    30. 6.27 RUSSIA MARKET ANALYSIS BY AGE GROUP |
    31. 6.28 ITALY MARKET ANALYSIS BY PROCEDURE TYPE |
    32. 6.29 ITALY MARKET ANALYSIS BY END USER |
    33. 6.30 ITALY MARKET ANALYSIS BY GENDER |
    34. 6.31 ITALY MARKET ANALYSIS BY AGE GROUP |
    35. 6.32 SPAIN MARKET ANALYSIS BY PROCEDURE TYPE |
    36. 6.33 SPAIN MARKET ANALYSIS BY END USER |
    37. 6.34 SPAIN MARKET ANALYSIS BY GENDER |
    38. 6.35 SPAIN MARKET ANALYSIS BY AGE GROUP |
    39. 6.36 REST OF EUROPE MARKET ANALYSIS BY PROCEDURE TYPE |
    40. 6.37 REST OF EUROPE MARKET ANALYSIS BY END USER |
    41. 6.38 REST OF EUROPE MARKET ANALYSIS BY GENDER |
    42. 6.39 REST OF EUROPE MARKET ANALYSIS BY AGE GROUP |
    43. 6.40 APAC MARKET ANALYSIS |
    44. 6.41 CHINA MARKET ANALYSIS BY PROCEDURE TYPE |
    45. 6.42 CHINA MARKET ANALYSIS BY END USER |
    46. 6.43 CHINA MARKET ANALYSIS BY GENDER |
    47. 6.44 CHINA MARKET ANALYSIS BY AGE GROUP |
    48. 6.45 INDIA MARKET ANALYSIS BY PROCEDURE TYPE |
    49. 6.46 INDIA MARKET ANALYSIS BY END USER |
    50. 6.47 INDIA MARKET ANALYSIS BY GENDER |
    51. 6.48 INDIA MARKET ANALYSIS BY AGE GROUP |
    52. 6.49 JAPAN MARKET ANALYSIS BY PROCEDURE TYPE |
    53. 6.50 JAPAN MARKET ANALYSIS BY END USER |
    54. 6.51 JAPAN MARKET ANALYSIS BY GENDER |
    55. 6.52 JAPAN MARKET ANALYSIS BY AGE GROUP |
    56. 6.53 SOUTH KOREA MARKET ANALYSIS BY PROCEDURE TYPE |
    57. 6.54 SOUTH KOREA MARKET ANALYSIS BY END USER |
    58. 6.55 SOUTH KOREA MARKET ANALYSIS BY GENDER |
    59. 6.56 SOUTH KOREA MARKET ANALYSIS BY AGE GROUP |
    60. 6.57 MALAYSIA MARKET ANALYSIS BY PROCEDURE TYPE |
    61. 6.58 MALAYSIA MARKET ANALYSIS BY END USER |
    62. 6.59 MALAYSIA MARKET ANALYSIS BY GENDER |
    63. 6.60 MALAYSIA MARKET ANALYSIS BY AGE GROUP |
    64. 6.61 THAILAND MARKET ANALYSIS BY PROCEDURE TYPE |
    65. 6.62 THAILAND MARKET ANALYSIS BY END USER |
    66. 6.63 THAILAND MARKET ANALYSIS BY GENDER |
    67. 6.64 THAILAND MARKET ANALYSIS BY AGE GROUP |
    68. 6.65 INDONESIA MARKET ANALYSIS BY PROCEDURE TYPE |
    69. 6.66 INDONESIA MARKET ANALYSIS BY END USER |
    70. 6.67 INDONESIA MARKET ANALYSIS BY GENDER |
    71. 6.68 INDONESIA MARKET ANALYSIS BY AGE GROUP |
    72. 6.69 REST OF APAC MARKET ANALYSIS BY PROCEDURE TYPE |
    73. 6.70 REST OF APAC MARKET ANALYSIS BY END USER |
    74. 6.71 REST OF APAC MARKET ANALYSIS BY GENDER |
    75. 6.72 REST OF APAC MARKET ANALYSIS BY AGE GROUP |
    76. 6.73 SOUTH AMERICA MARKET ANALYSIS |
    77. 6.74 BRAZIL MARKET ANALYSIS BY PROCEDURE TYPE |
    78. 6.75 BRAZIL MARKET ANALYSIS BY END USER |
    79. 6.76 BRAZIL MARKET ANALYSIS BY GENDER |
    80. 6.77 BRAZIL MARKET ANALYSIS BY AGE GROUP |
    81. 6.78 MEXICO MARKET ANALYSIS BY PROCEDURE TYPE |
    82. 6.79 MEXICO MARKET ANALYSIS BY END USER |
    83. 6.80 MEXICO MARKET ANALYSIS BY GENDER |
    84. 6.81 MEXICO MARKET ANALYSIS BY AGE GROUP |
    85. 6.82 ARGENTINA MARKET ANALYSIS BY PROCEDURE TYPE |
    86. 6.83 ARGENTINA MARKET ANALYSIS BY END USER |
    87. 6.84 ARGENTINA MARKET ANALYSIS BY GENDER |
    88. 6.85 ARGENTINA MARKET ANALYSIS BY AGE GROUP |
    89. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY PROCEDURE TYPE |
    90. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER |
    91. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY GENDER |
    92. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY AGE GROUP |
    93. 6.90 MEA MARKET ANALYSIS |
    94. 6.91 GCC COUNTRIES MARKET ANALYSIS BY PROCEDURE TYPE |
    95. 6.92 GCC COUNTRIES MARKET ANALYSIS BY END USER |
    96. 6.93 GCC COUNTRIES MARKET ANALYSIS BY GENDER |
    97. 6.94 GCC COUNTRIES MARKET ANALYSIS BY AGE GROUP |
    98. 6.95 SOUTH AFRICA MARKET ANALYSIS BY PROCEDURE TYPE |
    99. 6.96 SOUTH AFRICA MARKET ANALYSIS BY END USER |
    100. 6.97 SOUTH AFRICA MARKET ANALYSIS BY GENDER |
    101. 6.98 SOUTH AFRICA MARKET ANALYSIS BY AGE GROUP |
    102. 6.99 REST OF MEA MARKET ANALYSIS BY PROCEDURE TYPE |
    103. 6.100 REST OF MEA MARKET ANALYSIS BY END USER |
    104. 6.101 REST OF MEA MARKET ANALYSIS BY GENDER |
    105. 6.102 REST OF MEA MARKET ANALYSIS BY AGE GROUP |
    106. 6.103 KEY BUYING CRITERIA OF HEALTHCARE |
    107. 6.104 RESEARCH PROCESS OF MRFR |
    108. 6.105 DRO ANALYSIS OF HEALTHCARE |
    109. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
    110. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
    111. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE |
    112. 6.109 HEALTHCARE, BY PROCEDURE TYPE, 2024 (% SHARE) |
    113. 6.110 HEALTHCARE, BY PROCEDURE TYPE, 2024 TO 2035 (USD Billion) |
    114. 6.111 HEALTHCARE, BY END USER, 2024 (% SHARE) |
    115. 6.112 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion) |
    116. 6.113 HEALTHCARE, BY GENDER, 2024 (% SHARE) |
    117. 6.114 HEALTHCARE, BY GENDER, 2024 TO 2035 (USD Billion) |
    118. 6.115 HEALTHCARE, BY AGE GROUP, 2024 (% SHARE) |
    119. 6.116 HEALTHCARE, BY AGE GROUP, 2024 TO 2035 (USD Billion) |
    120. 6.117 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    121. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    122. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
      2. 7.2.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.2.3 BY GENDER, 2025-2035 (USD Billion) | |
      4. 7.2.4 BY AGE GROUP, 2025-2035 (USD Billion) |
    123. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.3.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
      2. 7.3.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.3.3 BY GENDER, 2025-2035 (USD Billion) | |
      4. 7.3.4 BY AGE GROUP, 2025-2035 (USD Billion) |
    124. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.4.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
      2. 7.4.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.4.3 BY GENDER, 2025-2035 (USD Billion) | |
      4. 7.4.4 BY AGE GROUP, 2025-2035 (USD Billion) |
    125. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.5.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
      2. 7.5.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.5.3 BY GENDER, 2025-2035 (USD Billion) | |
      4. 7.5.4 BY AGE GROUP, 2025-2035 (USD Billion) |
    126. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.6.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
      2. 7.6.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.6.3 BY GENDER, 2025-2035 (USD Billion) | |
      4. 7.6.4 BY AGE GROUP, 2025-2035 (USD Billion) |
    127. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.7.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
      2. 7.7.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.7.3 BY GENDER, 2025-2035 (USD Billion) | |
      4. 7.7.4 BY AGE GROUP, 2025-2035 (USD Billion) |
    128. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.8.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
      2. 7.8.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.8.3 BY GENDER, 2025-2035 (USD Billion) | |
      4. 7.8.4 BY AGE GROUP, 2025-2035 (USD Billion) |
    129. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.9.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
      2. 7.9.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.9.3 BY GENDER, 2025-2035 (USD Billion) | |
      4. 7.9.4 BY AGE GROUP, 2025-2035 (USD Billion) |
    130. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.10.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
      2. 7.10.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.10.3 BY GENDER, 2025-2035 (USD Billion) | |
      4. 7.10.4 BY AGE GROUP, 2025-2035 (USD Billion) |
    131. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.11.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
      2. 7.11.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.11.3 BY GENDER, 2025-2035 (USD Billion) | |
      4. 7.11.4 BY AGE GROUP, 2025-2035 (USD Billion) |
    132. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.12.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
      2. 7.12.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.12.3 BY GENDER, 2025-2035 (USD Billion) | |
      4. 7.12.4 BY AGE GROUP, 2025-2035 (USD Billion) |
    133. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.13.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
      2. 7.13.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.13.3 BY GENDER, 2025-2035 (USD Billion) | |
      4. 7.13.4 BY AGE GROUP, 2025-2035 (USD Billion) |
    134. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.14.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
      2. 7.14.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.14.3 BY GENDER, 2025-2035 (USD Billion) | |
      4. 7.14.4 BY AGE GROUP, 2025-2035 (USD Billion) |
    135. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.15.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
      2. 7.15.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.15.3 BY GENDER, 2025-2035 (USD Billion) | |
      4. 7.15.4 BY AGE GROUP, 2025-2035 (USD Billion) |
    136. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.16.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
      2. 7.16.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.16.3 BY GENDER, 2025-2035 (USD Billion) | |
      4. 7.16.4 BY AGE GROUP, 2025-2035 (USD Billion) |
    137. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.17.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
      2. 7.17.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.17.3 BY GENDER, 2025-2035 (USD Billion) | |
      4. 7.17.4 BY AGE GROUP, 2025-2035 (USD Billion) |
    138. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.18.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
      2. 7.18.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.18.3 BY GENDER, 2025-2035 (USD Billion) | |
      4. 7.18.4 BY AGE GROUP, 2025-2035 (USD Billion) |
    139. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.19.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
      2. 7.19.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.19.3 BY GENDER, 2025-2035 (USD Billion) | |
      4. 7.19.4 BY AGE GROUP, 2025-2035 (USD Billion) |
    140. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.20.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
      2. 7.20.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.20.3 BY GENDER, 2025-2035 (USD Billion) | |
      4. 7.20.4 BY AGE GROUP, 2025-2035 (USD Billion) |
    141. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.21.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
      2. 7.21.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.21.3 BY GENDER, 2025-2035 (USD Billion) | |
      4. 7.21.4 BY AGE GROUP, 2025-2035 (USD Billion) |
    142. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.22.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
      2. 7.22.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.22.3 BY GENDER, 2025-2035 (USD Billion) | |
      4. 7.22.4 BY AGE GROUP, 2025-2035 (USD Billion) |
    143. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.23.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
      2. 7.23.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.23.3 BY GENDER, 2025-2035 (USD Billion) | |
      4. 7.23.4 BY AGE GROUP, 2025-2035 (USD Billion) |
    144. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.24.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
      2. 7.24.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.24.3 BY GENDER, 2025-2035 (USD Billion) | |
      4. 7.24.4 BY AGE GROUP, 2025-2035 (USD Billion) |
    145. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.25.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
      2. 7.25.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.25.3 BY GENDER, 2025-2035 (USD Billion) | |
      4. 7.25.4 BY AGE GROUP, 2025-2035 (USD Billion) |
    146. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.26.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
      2. 7.26.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.26.3 BY GENDER, 2025-2035 (USD Billion) | |
      4. 7.26.4 BY AGE GROUP, 2025-2035 (USD Billion) |
    147. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.27.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
      2. 7.27.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.27.3 BY GENDER, 2025-2035 (USD Billion) | |
      4. 7.27.4 BY AGE GROUP, 2025-2035 (USD Billion) |
    148. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.28.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
      2. 7.28.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.28.3 BY GENDER, 2025-2035 (USD Billion) | |
      4. 7.28.4 BY AGE GROUP, 2025-2035 (USD Billion) |
    149. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.29.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
      2. 7.29.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.29.3 BY GENDER, 2025-2035 (USD Billion) | |
      4. 7.29.4 BY AGE GROUP, 2025-2035 (USD Billion) |
    150. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.30.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
      2. 7.30.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.30.3 BY GENDER, 2025-2035 (USD Billion) | |
      4. 7.30.4 BY AGE GROUP, 2025-2035 (USD Billion) |
    151. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.31.1 |
    152. 7.32 ACQUISITION/PARTNERSHIP | |

Healthcare Market Segmentation

Healthcare By Procedure Type (USD Billion, 2025-2035)

  • Liposuction
  • Mastectomy
  • Thyroid Hormone Therapy
  • Medications
  • Ultrasound

Healthcare By End User (USD Billion, 2025-2035)

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers

Healthcare By Gender (USD Billion, 2025-2035)

  • Male
  • Female

Healthcare By Age Group (USD Billion, 2025-2035)

  • Adolescents
  • Adults
  • Elderly

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions